DeepFacts builds AI tools to monitor patients in real time
By Abha Lohia · Editor ·
DeepFacts: funding and every story →
seedFounded 2020-12
- DeepFacts creates AI-powered devices to track patient vitals and alert doctors in real time The company raised ₹1 crore through grants and investments to…
What happened
- DeepFacts is a healthcare startup that builds AI tools to monitor patients in real time, especially in hospital wards and rooms.
- The company’s flagship product, proRITHM, is a wearable device that tracks key patient vitals such as heart rate, temperature, oxygen saturation, respiratory rate, and blood pressure.
- proRITHM sends this data in real time to a cloud-based dashboard, allowing doctors and nurses to monitor patients remotely and respond quickly to changes in condition.
- The device is designed to be worn on the chest and allows patients to move freely while still being monitored, reducing the need for frequent physical checks.
- proRITHM includes a feature that lets doctors set personalized thresholds for each patient, triggering alerts only when readings move outside those limits.
- The platform also calculates an early warning score to rate patient risk on a scale from one to seven, helping doctors intervene earlier if a patient’s condition worsens.
- proRITHM is classified as a medical-grade device under Class B and is CE self-certified, with the team working toward US FDA 510(k) clearance.
Why it matters
- The problem DeepFacts is solving is the lack of continuous monitoring for patients outside the ICU, where checks are often done only every few hours.
- This delay in monitoring can put patients at serious risk if something goes wrong between checks.
- proRITHM helps reduce the gap between patients and doctors by providing real-time data and early warnings.
- The device is designed to be used in both private and public healthcare systems, addressing a global issue in quality of care and patient safety.
The business
- DeepFacts focuses on improving patient care through real-time monitoring and early detection of health risks.
- The company’s product, proRITHM, is a wearable device that continuously tracks patient vitals and sends data to a cloud-based dashboard.
- The device is designed to be used in hospital wards and rooms, where monitoring is often less frequent than in ICUs.
- proRITHM includes features like personalized thresholds, early warning scores, and mobility support to enhance patient care and reduce infection risks.
- The company is working toward international regulatory approvals, including US FDA 510(k) clearance, to ensure its product meets global standards.
The founders
VK
Vamsi Karatam
founder- Vamsi Karatam spent nearly a decade working at IBM before starting DeepFacts.
- He founded DeepFacts in December 2020 with the goal of improving patient care through technology.
- He has participated in startup events and accelerator programs such as IIT Bombay’s Atman 3.0 program under the THH Foundation.
- Vamsi advises young entrepreneurs to build functional, testable products rather than waiting for a perfect one.
In numbers
₹1 crorefunds raised · 2020
Earlier rounds
- 2020 · funding · ₹1 crore
In their words
“Instead of waiting for a perfect product, founders should focus on building something functional, testable, and adaptable as this can significantly speed up learning and growth.”Vamsi Karatam, founder
Words to know
- proRITHM
- DeepFacts’ flagship product, a wearable device that tracks patient vitals and sends data to a cloud-based dashboard for real-time monitoring.
- Class B medical device
- A classification of medical devices that requires specific regulatory compliance and testing to ensure safety and effectiveness.
- early warning score
- A system that rates a patient’s risk level on a scale from one to seven, helping doctors intervene earlier if a patient’s condition worsens.
- FDA 510(k) clearance
- A regulatory process in the United States for medical devices to demonstrate that they are substantially equivalent to a legally marketed device.
The numbers around it
Healthcare & Life Sciences in January 2026: 12 rounds with a disclosed amount, $99.0 million in all; the biggest was Sukino ($31M). Every sector this year →
Read next
FundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centresLaunchKapiva gives away Dia Free Juice on World Diabetes DayKapiva is a Bengaluru-based Ayurveda wellness brand selling herbal juices and supplements, with a flagship juice aimed at people managing blood sugar
Everything on DeepFacts → · All startup news on 29 January 2026 →
Is this DeepFacts? Get your “Featured on StopDown” badge →